Cargando…

miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targetting c-Jun

Hypertrophic cardiomyopathy (HCM) is a serious monogenic disease characterized by cardiac hypertrophy, fibrosis, sudden cardiac death, and heart failure. Previously, we identified that miR-139-5p was down-regulated in HCM patients. However, the regulatory effects of miR-139-5p remain unclear. Thus,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ming, Su, Shui-yun, Wang, Wei, Qiu, Jian-hui, Li, Ru-tai, Hui, Lei, Song, Mei, Jia, Hui, Wang, Ji-zheng, Wang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843750/ https://www.ncbi.nlm.nih.gov/pubmed/29440459 http://dx.doi.org/10.1042/BSR20171430

Ejemplares similares

Circular RNA expression in isoproterenol hydrochloride-induced cardiac hypertrophy
por: Yang, Ming-Hui, et al.
Publicado: (2020)

Regulation of Oncogenic Targets by the Tumor-Suppressive miR-139 Duplex (miR-139-5p and miR-139-3p) in Renal Cell Carcinoma
por: Okada, Reona, et al.
Publicado: (2020)

Dendrobium candidum aqueous extract attenuates isoproterenol-induced cardiac hypertrophy through the ERK signalling pathway
por: Cao, Yuan-Yuan, et al.
Publicado: (2020)

Cardiac hypertrophy is negatively regulated by miR-541
por: Liu, F, et al.
Publicado: (2014)

miR-208a in Cardiac Hypertrophy and Remodeling
por: Huang, Xing-Huai, et al.
Publicado: (2021)

Tumor-suppressor role of miR-139-5p in endometrial cancer
por: Liu, JinHui, et al.
Publicado: (2018)

Protective Role for LPA(3) in Cardiac Hypertrophy Induced by Myocardial Infarction but Not by Isoproterenol
por: Cai, Lin, et al.
Publicado: (2017)

Hydrogen (H(2)) Inhibits Isoproterenol-Induced Cardiac Hypertrophy via Antioxidative Pathways
por: Zhang, Yaxing, et al.
Publicado: (2016)

Targeting miR-30d reverses pathological cardiac hypertrophy
por: Li, Jin, et al.
Publicado: (2022)

Carbamazepine alone and in combination with doxycycline attenuates isoproterenol-induced cardiac hypertrophy
por: Errami, Mounir, et al.
Publicado: (2010)

Combinational effect of resveratrol and atorvastatin on isoproterenol-induced cardiac hypertrophy in rats
por: Chakraborty, Songjukta, et al.
Publicado: (2015)

miR-217 Promotes Cardiac Hypertrophy and Dysfunction by Targeting PTEN
por: Nie, Xiang, et al.
Publicado: (2018)

Dual tumor‐suppressors miR‐139‐5p and miR‐139‐3p targeting matrix metalloprotease 11 in bladder cancer
por: Yonemori, Masaya, et al.
Publicado: (2016)

A novel functional polymorphism of GFAP decrease glioblastoma susceptibility through inhibiting the binding of miR-139
por: Wang, Jie, et al.
Publicado: (2018)

Exacerbation of diabetic cardiac hypertrophy in OVE26 mice by angiotensin II is associated with JNK/c-Jun/miR-221-mediated autophagy inhibition
por: Qian, Ling-Bo, et al.
Publicado: (2017)

miR-139-5p and miR-451a as a Diagnostic Biomarker in LUSC
por: Gao, Bo, et al.
Publicado: (2023)

The Expression of microRNA in Adult Rat Heart with Isoproterenol-Induced Cardiac Hypertrophy
por: Gan, Mailin, et al.
Publicado: (2020)

Syringic acid mitigates isoproterenol‐induced cardiac hypertrophy and fibrosis by downregulating Ereg
por: Han, Xiongyi, et al.
Publicado: (2022)

Altered Expressions of miR-1238-3p, miR-494, miR-6069, and miR-139-3p in the Formation of Chronic Brucellosis
por: Budak, Ferah, et al.
Publicado: (2016)

Impact of Oncogenic Targets by Tumor-Suppressive miR-139-5p and miR-139-3p Regulation in Head and Neck Squamous Cell Carcinoma
por: Koma, Ayaka, et al.
Publicado: (2021)

Implication of miR-126 and miR-139-5p in Plasmacytoid Dendritic Cell Dysregulation in Systemic Sclerosis
por: Chouri, Eleni, et al.
Publicado: (2021)

miR-125a, miR-139 and miR-324 contribute to Urocortin protection against myocardial ischemia-reperfusion injury
por: Díaz, Ignacio, et al.
Publicado: (2017)

Overexpression of miR-221 in sudden death with cardiac hypertrophy patients
por: Kakimoto, Yu, et al.
Publicado: (2018)

Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4
por: Li, Hui, et al.
Publicado: (2020)

Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice
por: Wang, Jian, et al.
Publicado: (2012)

H19 Overexpression Improved Efficacy of Mesenchymal Stem Cells in Ulcerative Colitis by Modulating the miR-141/ICAM-1 and miR-139/CXCR4 Axes
por: Zhao, Ming-li, et al.
Publicado: (2021)

Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway
por: Al-rasheed, Nouf M, et al.
Publicado: (2015)

Potential role of miR-139-5p in cancer diagnosis, prognosis and therapy
por: Huang, Ling-Li, et al.
Publicado: (2017)

Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure
por: Galindo, Cristi L, et al.
Publicado: (2009)

miR-218 Involvement in Cardiomyocyte Hypertrophy Is Likely through Targeting REST
por: Liu, Jing-Jing, et al.
Publicado: (2016)

Oxytocin Protects Against Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting PI3K/AKT Pathway via a lncRNA GAS5/miR-375-3p/KLF4-Dependent Mechanism
por: Yang, Yuqiao, et al.
Publicado: (2021)

miR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell Carcinoma
por: Chen, Zujian, et al.
Publicado: (2017)

miR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell Carcinoma
por: Chen, Zujian, et al.
Publicado: (2017)

STVNa Attenuates Isoproterenol-Induced Cardiac Hypertrophy Response through the HDAC4 and Prdx2/ROS/Trx1 Pathways
por: Liu, Fei, et al.
Publicado: (2020)

ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting miR-185
por: Tan, Bibo, et al.
Publicado: (2018)

The role of miR-139-5p in radioiodine-resistant thyroid cancer
por: Pecce, V., et al.
Publicado: (2023)

MiR-30e Attenuates Isoproterenol-induced Cardiac Fibrosis Through Suppressing Snai1/TGF-β Signaling
por: Zhang, Wenqi, et al.
Publicado: (2017)

miR-26b inhibits isoproterenol-induced cardiac fibrosis via the Keap1/Nrf2 signaling pathway
por: Xiang, Shaohua, et al.
Publicado: (2020)

miR-26b inhibits isoproterenol-induced cardiac fibrosis via the Keap1/Nrf2 signaling pathway
por: Xiang, Shaohua, et al.
Publicado: (2020)

Predictive values of miR-129 and miR-139 for efficacy on patients with prostate cancer after chemotherapy and prognostic correlation
por: Hu, Zhongchun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2unll1cq17da0q1fsbdnh81qhe